SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • May 9th, 2019 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
Contract Type FiledMay 9th, 2019 Company Industry JurisdictionTHIS SEVERANCE AND CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of March 18, 2019 (the “Effective Date”) is entered into by and between Andreas Grauer, M.D., Chief Medical Officer (“CMO”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).